These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 23946118)
1. Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene. Alder JK; Parry EM; Yegnasubramanian S; Wagner CL; Lieblich LM; Auerbach R; Auerbach AD; Wheelan SJ; Armanios M Hum Mutat; 2013 Nov; 34(11):1481-5. PubMed ID: 23946118 [TBL] [Abstract][Full Text] [Related]
2. Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations. Xu J; Khincha PP; Giri N; Alter BP; Savage SA; Wong JM Am J Hematol; 2016 Dec; 91(12):1215-1220. PubMed ID: 27570172 [TBL] [Abstract][Full Text] [Related]
3. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081 [TBL] [Abstract][Full Text] [Related]
4. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report. Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475 [TBL] [Abstract][Full Text] [Related]
5. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita. Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374 [TBL] [Abstract][Full Text] [Related]
6. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients. Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review. Wang P; Xu Z BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523 [TBL] [Abstract][Full Text] [Related]
8. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826 [TBL] [Abstract][Full Text] [Related]
9. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Vulliamy TJ; Dokal I Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470 [TBL] [Abstract][Full Text] [Related]
11. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation. Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260 [TBL] [Abstract][Full Text] [Related]